Calvin Sandra

Calvin Sandra is listed in filings as SVP at Travere Therapeutics, Inc.. This profile follows SEC Form 4 activity through Apr 16, 2026, including sale activity. Recent filings connect the profile to Travere Therapeutics, Inc. (TVTX). The current snapshot covers public activity from Feb 4, 2025 to Apr 16, 2026. Reported amounts are shown as $532.0K to $231.1K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.